Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$8.02 - $8.67 $1,604 - $1,734
-200 Reduced 1.83%
10,749 $91,000
Q3 2023

Oct 31, 2023

BUY
$7.85 - $8.94 $85,949 - $97,884
10,949 New
10,949 $91,000
Q4 2022

Feb 13, 2023

BUY
$5.96 - $8.06 $61,465 - $83,122
10,313 New
10,313 $82,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Delta Financial Group, Inc. Portfolio

Follow Delta Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Delta Financial Group, Inc. with notifications on news.